Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, enumerate the major landscape shifts over the past 5 years in treating MM, including an increasing number of treatment options, the emergence of MRD testing to guide therapy, the availability of clinical trials, and the deeper, more durable responses new agents provide.
Video Library —June 22, 2020
Categories:
Interview with the Innovators
Advanced Practice Provider Chief, Winship Cancer Institute,
Emory University,
Atlanta, GA
Emory University,
Atlanta, GA
Clinical Pharmacy Specialist, Multiple Myeloma, and PGY2 Oncology Residency Research Coordinator,
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA
Nurse Practitioner, Inpatient and Outpatient Malignant Hematology,
Levine Cancer Institute,
Charlotte, NC
Levine Cancer Institute,
Charlotte, NC
Last modified: August 10, 2023
